Public Calendar: September 29 - October 5, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs
Event Date: 10/01/2019
Location: Silver Spring, MD
Subject: Food and Drug Administration Alumni Association Fall Fling
FDA Participant/Group: ANNA ABRAM; CHEN ZHUANG; KEAGAN LENIHAN; MARY LOU VALDEZ; STACY AMIN; DENISE HINTON; MITCHELL ZELLER; JEFFREY SHUREN; STANLEY MILSTEIN; HUONG HUYNH; DAYLE CRISTINZIO; SUSAN MAYNE; MARGARET KOBER; LAURA CALIGUIRI; LAUREN ROTH; SEGARAN PILLAI; JAN JOHANNESSEN;
Non FDA Participant/Group: Christine Kirk (Arnall Golden Gregory LLP); Bill Schultz, Peggy Dotzel (Zuckerman Spader LLP); Deb Autor, Denyse Baker, Julie Luan (AstraZeneca); Allen Sayler (EAS Consulting Group); Elizabeth Miller, Jennifer Devine (US Pharmacopeia); Lisa Barclay (Bois, Schiller & Flexner, LLP); Fredda Shere-Valenti, Larry Bachorik, Larry Dusold, Lois Beaver, Martha O'Connor, Nancy Pirt, Sandra Whetstone, Stuart Nightingale, Walter Batts (Retired); Mel Greberman (Public Health Resources); Carolina Wirth (Porizo, Bromberg & Newman, PC); Jane Axelrad (Axelrad Solutions LLC); Steven Immergut (Bayer); Qi Chen (Corporate Occupational Health Solutions, LLC); Jeanne Ireland (Ireland Strategies LLC); Bryant Godfrey (Arnold & Porter); Peter Rheinstein (Severn Health Solutions); Joe Levitt (Hogan Lovells US LLP); Eric Sheinin (Sheinin and Associates); Howard Sklamberg (Akin Gump Strauss Hauer & Feld LLP); Sheila Walcoff (Goldbug Strategies LLC); Khyati Roberts (Abbvie); Ed Steele (EAS Consulting Group LLC); Larry Bai (Mylan); Jethro Ekuta (Regulatory Affairs Professionals Society (RAPS)); Angela Hoague (The Levinson Group); Michael Klein (Controlled Substances Scientific Solutions LLC); Bob Guidos (Corning); Dan Orr (Womble Bond Dickinson (US) LLP); Joe Famulare (Genentech); Paula Katz (Covington & Burling LLP); Susan Winckler (Leavitt Partners); Nancy Myers (Catalyst Consulting); Ben Lewis (Lewis Regulatory Consulting LLC); Emmanuelle Voisin (Voisin Consulting Life Sciences);
Event Date: 10/02/2019
Location: Silver Spring, MD
Subject: Food and Drug Administration Executive Committee Meeting with Reagan-Udall Foundation: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Reagan-Udall Foundation members
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 09/30/2019
Location: Washington, DC
Subject: National Academy Medicine (NAM) Leadership Consortium Member Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from multiple sectors including government, healthcare industry, academia, and consumer and patient advocates
Event Date: 10/03/2019
Location: Silver Spring, MD
Subject: External Listening Session Center for Science in the Public Interest (CSPI)
FDA Participant/Group: BETH FRITSCH; MELISSA ROBB; DAYLE CRISTINZIO; ROBIN APPLEBERRY; SHARON MAYL; CARA WELCH; STEVEN TAVE; DOUGLAS THROCKMORTON; DENNIS KEEFE; RACHEL OSTERMAN; CLAUDIA AHIABOR; LOWELL SCHILLER; MICHAEL ADAMS; APRIL ALEXANDROW; REBECCA GOLDBERG; SHERENE SEPEHRI; MICHAEL LEVY; TRISTAN COLONIUS; JOSEPH FRANKLIN;
Non FDA Participant/Group: Lynn Silver (Public Health Institute); Laura MacCleery (Center for Science in the Public Interest);
Event Date: 10/03/2019
Location: Silver Spring, MD
Subject: External Listening Session Canopy Growth USA
FDA Participant/Group: DENNIS KEEFE; RACHEL OSTERMAN; SHARON MAYL; JOSEPH FRANKLIN; APRIL ALEXANDROW; CARA WELCH; REBECCA GOLDBERG; BETH FRITSCH; DAYLE CRISTINZIO; ROBERT DURKIN; DOUGLAS THROCKMORTON; MELISSA ROBB; CHARLOTTE CONWAY; LOWELL SCHILLER;
Non FDA Participant/Group: David Culver, Hunter Land, Kelly D. Fair, Marcel Bonn-Miller, Reinhold Krahn (Canopy Growth Corp.); Jessica O’Connell (Covington & Burling LLP);
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 10/01/2019
Location: Schaumburg, IL
Subject: Food Safety Consortium Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Food industry executives, associations, academia, and government
Event Date: 10/02/2019
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR;
Non FDA Participant/Group: Mark Killian (Arizona Department of Agriculture);
Event Date: 10/03/2019
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Shelley Fiest (Partnership for Food Safety Education);
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 10/02/2019
Location: Philadelphia, PA
Subject: Temple University Regulatory Affairs and Quality Assurance 50th Anniversary Celebration
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 10/01/2019
Location: Washington, DC
Subject: Meeting with AIDS United
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 10/03/2019
Location: San Diego, CA
Subject: 2019 Cell & Gene Meeting on the Mesa: Advancing Gene Therapies Great and Small
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 10/03/2019
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: SETH CARMODY; FRANCISCO VICENTY; BAKUL PATEL; BLETA VUNIQI;
Non FDA Participant/Group: Erin Williams, Heather Hawley, Kim Warren (The MITRE Corporation);
Event Date: 10/03/2019
Location: Silver Spring, MD
Subject: Early Cancer Detection
FDA Participant/Group: ELIZABETH HILLEBRENNER;
Non FDA Participant/Group: Christoph Lengauer, Dave Daly, Seema Singh Bhan, Steve Kafka (Thrive Earlier Detection);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 10/01/2019
Location: Kansas City, MO
Subject: National Grain and Feed Association - Pet Food Institute Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: National Grain and Feed Association
Event Date: 10/04/2019
Location: Rockville, MD
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: HEATHER LOMBARDI; TIMOTHY SCHELL; DAVID EDWARDS; JULI ANN PUTNAM; MARY ALLEN; JEREMIAH FASANO; TRACEY FORFA; MICHAEL MYERS; JACOB FROEHLICH;
Non FDA Participant/Group: Human Society Legislative Fund
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date: 09/30/2019
Location: Little Rock, AR
Subject: Arkansas Chapter of the Society for Neuroscience Annual Meeting
FDA Participant/Group: WILLIAM SLIKKER;
Non FDA Participant/Group: Government, academia, and other invited guests
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event